| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine
|
Kümler, I.
|
|
2019
|
84 |
2 |
p. 441-446
|
artikel
|
| 2 |
A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer
|
Jin, Guoying
|
|
2019
|
84 |
2 |
p. 315-325
|
artikel
|
| 3 |
A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer
|
Kato, Yasuhiro
|
|
2019
|
84 |
2 |
p. 351-358
|
artikel
|
| 4 |
Cancer immunotherapy: the art of targeting the tumor immune microenvironment
|
Silva, Jesse Lopes da
|
|
2019
|
84 |
2 |
p. 227-240
|
artikel
|
| 5 |
CNS penetration of the CDK4/6 inhibitor ribociclib in non-tumor bearing mice and mice bearing pediatric brain tumors
|
Patel, Yogesh T.
|
|
2019
|
84 |
2 |
p. 447-452
|
artikel
|
| 6 |
Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis
|
Pétain, Aurélie
|
|
2019
|
84 |
2 |
p. 373-382
|
artikel
|
| 7 |
Exposure time versus cytotoxicity for anticancer agents
|
Evans, David M.
|
|
2019
|
84 |
2 |
p. 359-371
|
artikel
|
| 8 |
Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patients
|
Hosoya, Kazutaka
|
|
2019
|
84 |
2 |
p. 275-280
|
artikel
|
| 9 |
MicroRNA-552 deficiency mediates 5-fluorouracil resistance by targeting SMAD2 signaling in DNA-mismatch-repair-deficient colorectal cancer
|
Zhao, Ping
|
|
2019
|
84 |
2 |
p. 427-439
|
artikel
|
| 10 |
Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations
|
Nobre, Carmen F.
|
|
2019
|
84 |
2 |
p. 255-263
|
artikel
|
| 11 |
MSI2-TGF-β/TGF-β R1/SMAD3 positive feedback regulation in glioblastoma
|
Jiang, Xingjun
|
|
2019
|
84 |
2 |
p. 415-425
|
artikel
|
| 12 |
Neoadjuvant chemotherapy in patients with advanced endometrial cancer
|
Khouri, Olivia R.
|
|
2019
|
84 |
2 |
p. 281-285
|
artikel
|
| 13 |
Oxaliplatin induces prostaglandin E2 release in vascular endothelial cells
|
Matsunuma, Satoru
|
|
2019
|
84 |
2 |
p. 345-350
|
artikel
|
| 14 |
Phase I study of BGT226, a pan-PI3K and mTOR inhibitor, in Japanese patients with advanced solid cancers
|
Minami, Hironobu
|
|
2019
|
84 |
2 |
p. 337-343
|
artikel
|
| 15 |
Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors
|
Doi, Toshihiko
|
|
2019
|
84 |
2 |
p. 393-404
|
artikel
|
| 16 |
Postoperative chemotherapy as adjuvant treatment for endometrioid adenocarcinoma: early stage vs late stage
|
Lu, Mengmeng
|
|
2019
|
84 |
2 |
p. 299-305
|
artikel
|
| 17 |
Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors
|
Kim, Gyuri
|
|
2019
|
84 |
2 |
p. 405-414
|
artikel
|
| 18 |
Priming with GM-CSF instead of G-CSF enhances CAG-induced apoptosis of acute monocytic leukemia cells in vitro
|
Lei, Meiqing
|
|
2019
|
84 |
2 |
p. 265-273
|
artikel
|
| 19 |
Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody–drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII
|
Rosenthal, Mark
|
|
2019
|
84 |
2 |
p. 327-336
|
artikel
|
| 20 |
Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer
|
Suzuki, Takeshi
|
|
2019
|
84 |
2 |
p. 307-313
|
artikel
|
| 21 |
SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4
|
Wong, Deysi Viviana Tenazoa
|
|
2019
|
84 |
2 |
p. 287-298
|
artikel
|
| 22 |
The effects of lapatinib on cardiac repolarization: results from a placebo controlled, single sequence, crossover study in patients with advanced solid tumors
|
Coker, Shodeinde A.
|
|
2019
|
84 |
2 |
p. 383-392
|
artikel
|
| 23 |
The role of apoptosis defects in malignant mesothelioma pathogenesis with an impact on prognosis and treatment
|
Galani, Vasiliki
|
|
2019
|
84 |
2 |
p. 241-253
|
artikel
|
Tijdschrift beschrijving